Pegfilgrastim overdose: Case report and review of the literature

Orit Kaidar-Person, Mor Moskovitz, Tomer Charas, Wasim Alsharbati, Nissim Haim

Research output: Contribution to journalReview articlepeer-review


Single-dose pegfilgrastim is commonly used for the prophylaxis of neutropenia in patients receiving myelotoxic chemotherapy. We report a case of a 69-year-old man who was treated with chemotherapy for small-cell lung cancer and mistakenly self-administered a 36 mg overdose of pegfilgrastim, a sixfold increase over the scheduled dose.

Original languageEnglish
Pages (from-to)S697-S698
JournalMedical Oncology
Issue numberSUPPL. 1
StatePublished - Dec 2011
Externally publishedYes


  • Chemotherapy
  • G-CSF
  • Neutropenia
  • Overdose
  • Pegfilgrastim


Dive into the research topics of 'Pegfilgrastim overdose: Case report and review of the literature'. Together they form a unique fingerprint.

Cite this